Anat Loewenstein Talks ForeSeeHome, Unmet Needs in Retinal Disease

Video

The biggest unmet need nowadays in retina disease is geographic atrophy..."

In the second installment of MD Magazine’s sitdown with Tel Aviv Medical Center Ophthalmology Department Chair Anat Loewenstein, she spoke of needs to be addressed in the treatment of patients with retina diseases as well as other projects she is involved in.

“I think the biggest unmet need nowadays in retina disease is geographic atrophy and the need for frequent treatment and monitoring,” she said.

“I’m involved in many research projects, and I think the most exciting ones have to do with monitoring of the disease and with automated detection of choroidal neovascular activity,” Loewenstein said, before discussing ForeSeeHome, the home-based age-related macular degeneration monitoring device that she expects to be adopted worldwide in the coming years.

Related Videos
Dolly Chang, MD, PhD | Image Credit: LinkedIn
Evaluating MM120 for GAD with Daniel Karlin, MD, and Reid Robinson, MD, MBA
Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
Daniela Ferrara, MD, PhD: Machine Learning Predicts Functional Outcomes in DME | Image Credit: Ophthalmology Innovation Summit
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
© 2024 MJH Life Sciences

All rights reserved.